Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood
文献类型:期刊论文
作者 | Chen, Shuzhen8,9; Dong, Yaping5,6,8,9; Qi, Xinming7; Cao, Qiqi8,9; Luo, Tao3,4; Bai, Zhaofang2; He, Huisi8,9; Fan, Zhecai8,9; Xu, Lingyan8,9; Xing, Guozhen7 |
刊名 | ACTA PHARMACEUTICA SINICA B |
出版日期 | 2022-05-01 |
卷号 | 12期号:5页码:2252-2267 |
ISSN号 | 2211-3835 |
关键词 | Aristolochic acids (AAs) Mutational signature AA-DNA adduct Hepatocellular carcinoma (HCC) Liver tumorigenesis Hepatitis B virus (HBV) Risk factors Tumor prevention |
DOI | 10.1016/j.apsb.2021.11.0112211-3835 |
通讯作者 | Wen, Wen(wenwen_smmu@163.com) ; Ren, Jin(jren@cdser.simm.ac.cn) ; Wang, Hongyang(hywangk@vip.sina.com) |
英文摘要 | Aristolochic acids (AAs) have long been considered as a potent carcinogen due to its nephrotoxicity. Aristolochic acid I (AAI) reacts with DNA to form covalent aristolactam (AL)-DNA adducts, leading to subsequent A to T transversion mutation, commonly referred as AA mutational signature. Previous research inferred that AAs were widely implicated in liver cancer throughout Asia. In this study, we explored whether AAs exposure was the main cause of liver cancer in the context of HBV infection in mainland China. Totally 1256 liver cancer samples were randomly retrieved from 3 medical centers and a refined bioanalytical method was used to detect AAI-DNA adducts. 5.10% of these samples could be identified as AAI positive exposure. Whole genome sequencing suggested 8.41% of 107 liver cancer patients exhibited the dominant AA mutational signature, indicating a relatively low overall AAI exposure rate. In animal models, long-term administration of AAI barely increased liver tumorigenesis in adult mice, opposite from its tumor-inducing role when subjected to infant mice. Furthermore, AAI induced dose-dependent accumulation of AA-DNA adduct in target organs in adult mice, with the most detected in kidney instead of liver. Taken together, our data indicate that AA exposure was not the major threat of liver cancer in adulthood. ?? 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
WOS关键词 | ARISTOLACTAM-DNA ADDUCTS ; CELL-PROLIFERATION ; MOUSE-LIVER ; TISSUES ; MUTAGENICITY ; PATHOGENESIS ; PERSISTENCE ; FIBROSIS ; GENE |
资助项目 | Shanghai Key Laboratory of Hepatobiliary Tumor Biology ; National Major Scientific and Technological Special Project for Significant New Drugs Development (China)[2018ZX09101002] ; National Major Scientific and Technological Special Project for Significant New Drugs Development (China)[2018ZX09101002-001-001] ; National Major Scientific and Technological Special Project for Significant New Drugs Development (China)[2018ZX09101002-001-002] ; National Natural Science Foundation of China[81830054] ; National Natural Science Foundation of China[91859205] ; National Natural Science Foundation of China[81988101] ; National Natural Science Foundation of China[81722034] ; National Natural Science Foundation of China[81802878] ; Shanghai Pujiang Program (China)[2019PJD059] ; Shanghai Sailing Program (China)[18YF1400200] ; Key Discipline Project of Shanghai Municipal Education Commission (China)[201901070007E00065] ; Ministry of Education Key Laboratory on Signaling Regulation and Military Key Laboratory and Targeting Therapy of Liver Cancer, Second Military Medical University, Shanghai, China |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
WOS记录号 | WOS:000810889400008 |
源URL | [http://119.78.100.183/handle/2S10ELR8/301714] |
专题 | 新药研究国家重点实验室 |
通讯作者 | Wen, Wen; Ren, Jin; Wang, Hongyang |
作者单位 | 1.Second Mil Med Univ, Fac Med Serv, Dept Hlth Stat, Shanghai 200438, Peoples R China 2.Chinese Peoples Liberat Army Gen Hosp, China Mil Inst Chinese Mat, Med Ctr 5, Beijing 100039, Peoples R China 3.Minist Educ China, Key Lab Tumor Immunopathol, Chongqing 400038, Peoples R China 4.Third Mil Med Univ, Southwest Hosp, Inst Pathol, Army Med Univ, Chongqing 400038, Peoples R China 5.Fujian Med Univ, Grad Sch, Fuzhou 350122, Peoples R China 6.Fudan Univ, Shanghai Canc Ctr, Shanghai 200032, Peoples R China 7.Chinese Acad Sci, Ctr Drug Safety Evaluat & Res, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China 8.Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China 9.Second Mil Med Univ, Natl Ctr Liver Canc, Shanghai 200438, Peoples R China |
推荐引用方式 GB/T 7714 | Chen, Shuzhen,Dong, Yaping,Qi, Xinming,et al. Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood[J]. ACTA PHARMACEUTICA SINICA B,2022,12(5):2252-2267. |
APA | Chen, Shuzhen.,Dong, Yaping.,Qi, Xinming.,Cao, Qiqi.,Luo, Tao.,...&Wang, Hongyang.(2022).Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood.ACTA PHARMACEUTICA SINICA B,12(5),2252-2267. |
MLA | Chen, Shuzhen,et al."Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood".ACTA PHARMACEUTICA SINICA B 12.5(2022):2252-2267. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。